Particle Therapy Market-converted
                     Particle Therapy Market  - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027 
Particle therapy is a form of external beam radiotherapy that is used in the treatment of various types of 
cancers such as prostate cancer, brain, tumors near the spine, pediatric cancer, 
gastrointestinal cancer, and melanoma of the eye. Moreover, for the treatment of cancer, a beam of 
energetic neutrons, protons or other heavier positive ion particles are used at the target tumors. These 
particles damage the tissue of DNA cell. 
Particle therapy is considered as safer and effective than the conventional radiation therapy, as particle 
therapy can deliver high dose to the specific area without affecting the surrounding tissue areas. 
We do offer sample of this report. Kindly go through the follow information in order to access sample 
copy:-  https://www.coherentmarketinsights.com/insight/request-sample/3574  
The increasing prevalence of various types of cancers is a major factor driving the growth of the global 
particle therapy market. For instance, in 2018, according to the World Health Organization (WHO), 
cancer was the second leading cause of death and accounted for 9.6 million (about one in six deaths 
were due to cancer) deaths, globally. In addition, colorectal, stomach, lung, prostate, and liver 
cancer are common in men while breast, colorectal, lung, and thyroid cancer are common in women. 
The increasing adoption of inorganic growth strategies such as collaboration by key players is another 
factor fueling growth of the global particle therapy market. For instance, in 2017, Royal Philips and 
Proton Partners International collaborated with Ion Beam Application (IBA). The main objective of the 
collaboration was to establish first compact proton therapy system in the Middle East. Hence, these 
factors are expected to drive the global particle therapy market growth over the forecast period. 
High cost associated with particle therapy treatment of cancer is a major factor hampering growth of 
the market. For instance, in 2017, the cost of proton therapy is anywhere between US$ 30,000 to US$ 
120,000. On the other hand, a course of treatment with radiosurgery is around US$ 8,000 to US$ 12,000. 
Therefore, high cost of cancer treatment using particle therapy is expected to result in low demand for 
particle therapy over conventional radiation therapy. 
North America is expected to hold dominant position in the global particle therapy market over the 
forecast period. The increasing prevalence of various types of cancers such as prostate cancer is one of 
the major factors driving growth of the particle therapy market in this region. For instance, in 2018, in 
the U.S, according to the American Cancer Society (ACS), 164,690 new cases of prostate cancer and over 
29,430 related deaths were reported. In addition, according to the same source, around 60% of the 
prostate cancer patients (men) of 65 years or older were diagnosed in 2018, in the U.S. Also, one in 
every nine men is expected to be diagnosed with prostate cancer. 
Asia Pacific is expected to exhibit highest CAGR over the forecast period due to rising number of patients 
suffering from cancer. For instance, according to the WHO, around 70% of deaths are due to cancer in 
developing countries of Asia Pacific region.Increasing development of various cancer centers and proton 
therapy centers in the Asia Pacific region is expected propel Asia Pacific particle therapy market growth. 
For instance, in 2016, Shenzhen Hairong International Medical Development and Provision Asia entered 
into a joint venture to form Provision China and main objective of the company was to develop cancer 
center as well as proton center. 
Some of the key players operating in the global particle therapy market include Ion Beam Applications, 
Provision Healthcare, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, 
Inc., Advanced Oncotherapy Plc., Varian Medical Systems, Inc., Hitachi, Ltd., Danfysik A/S, Provision 
Healthcare, LLC, and IBA Worldwide. 
Get the Main link:- https://www.coherentmarketinsights.com/ongoing-insight/particle-therapy-market-
3574 
ContactUs: 
Mr.Shah 
Coherent Market ,Insights 
10014thAve, 
#3200 
Seattle,WA98154 
Tel:+1-206-701-6702 
Email: [email protected]